InsidersTradesSigma
삼성바이오로직스 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 삼성바이오로직스 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 삼성바이오로직스 has logged 117 reports. Market capitalisation: €60,363.4bn. The latest transaction was filed on 20 May 2026 (Other). Among the most active insiders: 이재선. The full history is free.
117
Insider Decl.
0
Thresholds
·
6 ops.
Buy Volume
·
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 삼성바이오로직스 Strong Buy (bullish), based on 23 analysts. Average price target: ₩2,096,122.
Fundamental score
Ranked 7,994 of 26,213 companies
61.2
score / 100
Value38
Quality84
FCF yld1.2%
Earn yld2.8%
EV/EBITDA23.6x
ROE18%
Gross mgn55%
Net mgn39%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 20 May 2026
Declarations117 total
25 of 117 declarations